mtt kit Search Results


mtt cell viability assay kit  (Biotium)
95
Biotium mtt cell viability assay kit
Letrozole and ruxolitinib demonstrate synergy in ovarian cancer cell lines. ERα-high ovarian cancer cell lines OVCAR3 and OVCAR8 were treated with a range of doses of ruxolitinib (Rux) and letrozole (Let) at ratio of 1:2 and <t>cell</t> <t>viability</t> quantified by <t>MTT</t> assay. The combination index (CI) was determined using Compusyn applying the Chou-Talalay method. ( A ) The CI relative to the fraction affected (Fa) is shown for OVCAR3 and OVCAR8. CI at 75% inhibition for each cell line is shown, with values < 1 indicating synergy. ( B ) Colony formation assay for OVCAR8 and graphical representation demonstrating synergy in the colony formation assay.
Mtt Cell Viability Assay Kit, supplied by Biotium, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mtt cell viability assay kit/product/Biotium
Average 95 stars, based on 1 article reviews
mtt cell viability assay kit - by Bioz Stars, 2026-03
95/100 stars
  Buy from Supplier
tacs mtt cell proliferation assay kit  (Bio-Techne corporation)
90
Bio-Techne corporation tacs mtt cell proliferation assay kit
Letrozole and ruxolitinib demonstrate synergy in ovarian cancer cell lines. ERα-high ovarian cancer cell lines OVCAR3 and OVCAR8 were treated with a range of doses of ruxolitinib (Rux) and letrozole (Let) at ratio of 1:2 and <t>cell</t> <t>viability</t> quantified by <t>MTT</t> assay. The combination index (CI) was determined using Compusyn applying the Chou-Talalay method. ( A ) The CI relative to the fraction affected (Fa) is shown for OVCAR3 and OVCAR8. CI at 75% inhibition for each cell line is shown, with values < 1 indicating synergy. ( B ) Colony formation assay for OVCAR8 and graphical representation demonstrating synergy in the colony formation assay.
Tacs Mtt Cell Proliferation Assay Kit, supplied by Bio-Techne corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/tacs mtt cell proliferation assay kit/product/Bio-Techne corporation
Average 90 stars, based on 1 article reviews
tacs mtt cell proliferation assay kit - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
mtt assay kit  (Keygen Biotech)
90
Keygen Biotech mtt assay kit
Letrozole and ruxolitinib demonstrate synergy in ovarian cancer cell lines. ERα-high ovarian cancer cell lines OVCAR3 and OVCAR8 were treated with a range of doses of ruxolitinib (Rux) and letrozole (Let) at ratio of 1:2 and <t>cell</t> <t>viability</t> quantified by <t>MTT</t> assay. The combination index (CI) was determined using Compusyn applying the Chou-Talalay method. ( A ) The CI relative to the fraction affected (Fa) is shown for OVCAR3 and OVCAR8. CI at 75% inhibition for each cell line is shown, with values < 1 indicating synergy. ( B ) Colony formation assay for OVCAR8 and graphical representation demonstrating synergy in the colony formation assay.
Mtt Assay Kit, supplied by Keygen Biotech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mtt assay kit/product/Keygen Biotech
Average 90 stars, based on 1 article reviews
mtt assay kit - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
mtt cell count kit  (Nacalai)
90
Nacalai mtt cell count kit
Letrozole and ruxolitinib demonstrate synergy in ovarian cancer cell lines. ERα-high ovarian cancer cell lines OVCAR3 and OVCAR8 were treated with a range of doses of ruxolitinib (Rux) and letrozole (Let) at ratio of 1:2 and <t>cell</t> <t>viability</t> quantified by <t>MTT</t> assay. The combination index (CI) was determined using Compusyn applying the Chou-Talalay method. ( A ) The CI relative to the fraction affected (Fa) is shown for OVCAR3 and OVCAR8. CI at 75% inhibition for each cell line is shown, with values < 1 indicating synergy. ( B ) Colony formation assay for OVCAR8 and graphical representation demonstrating synergy in the colony formation assay.
Mtt Cell Count Kit, supplied by Nacalai, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mtt cell count kit/product/Nacalai
Average 90 stars, based on 1 article reviews
mtt cell count kit - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide  (Cayman Chemical)
90
Cayman Chemical 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide
Letrozole and ruxolitinib demonstrate synergy in ovarian cancer cell lines. ERα-high ovarian cancer cell lines OVCAR3 and OVCAR8 were treated with a range of doses of ruxolitinib (Rux) and letrozole (Let) at ratio of 1:2 and <t>cell</t> <t>viability</t> quantified by <t>MTT</t> assay. The combination index (CI) was determined using Compusyn applying the Chou-Talalay method. ( A ) The CI relative to the fraction affected (Fa) is shown for OVCAR3 and OVCAR8. CI at 75% inhibition for each cell line is shown, with values < 1 indicating synergy. ( B ) Colony formation assay for OVCAR8 and graphical representation demonstrating synergy in the colony formation assay.
3 (4,5 Dimethylthiazol 2 Yl) 2,5 Diphenyltetrazolium Bromide, supplied by Cayman Chemical, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide/product/Cayman Chemical
Average 90 stars, based on 1 article reviews
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
mtt cell proliferation assay  (Boehringer Mannheim)
90
Boehringer Mannheim mtt cell proliferation assay
Letrozole and ruxolitinib demonstrate synergy in ovarian cancer cell lines. ERα-high ovarian cancer cell lines OVCAR3 and OVCAR8 were treated with a range of doses of ruxolitinib (Rux) and letrozole (Let) at ratio of 1:2 and <t>cell</t> <t>viability</t> quantified by <t>MTT</t> assay. The combination index (CI) was determined using Compusyn applying the Chou-Talalay method. ( A ) The CI relative to the fraction affected (Fa) is shown for OVCAR3 and OVCAR8. CI at 75% inhibition for each cell line is shown, with values < 1 indicating synergy. ( B ) Colony formation assay for OVCAR8 and graphical representation demonstrating synergy in the colony formation assay.
Mtt Cell Proliferation Assay, supplied by Boehringer Mannheim, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mtt cell proliferation assay/product/Boehringer Mannheim
Average 90 stars, based on 1 article reviews
mtt cell proliferation assay - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
3-(4,5-dimethylthiazon-2-yl)-2,5-diphenyltetrazolium bromide (mtt) cell proliferation kit  (Boehringer Mannheim)
90
Boehringer Mannheim 3-(4,5-dimethylthiazon-2-yl)-2,5-diphenyltetrazolium bromide (mtt) cell proliferation kit
Letrozole and ruxolitinib demonstrate synergy in ovarian cancer cell lines. ERα-high ovarian cancer cell lines OVCAR3 and OVCAR8 were treated with a range of doses of ruxolitinib (Rux) and letrozole (Let) at ratio of 1:2 and <t>cell</t> <t>viability</t> quantified by <t>MTT</t> assay. The combination index (CI) was determined using Compusyn applying the Chou-Talalay method. ( A ) The CI relative to the fraction affected (Fa) is shown for OVCAR3 and OVCAR8. CI at 75% inhibition for each cell line is shown, with values < 1 indicating synergy. ( B ) Colony formation assay for OVCAR8 and graphical representation demonstrating synergy in the colony formation assay.
3 (4,5 Dimethylthiazon 2 Yl) 2,5 Diphenyltetrazolium Bromide (Mtt) Cell Proliferation Kit, supplied by Boehringer Mannheim, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/3-(4,5-dimethylthiazon-2-yl)-2,5-diphenyltetrazolium bromide (mtt) cell proliferation kit/product/Boehringer Mannheim
Average 90 stars, based on 1 article reviews
3-(4,5-dimethylthiazon-2-yl)-2,5-diphenyltetrazolium bromide (mtt) cell proliferation kit - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
cell quanti-mtt cell viability assay kit  (BioAssay Systems LLC)
90
BioAssay Systems LLC cell quanti-mtt cell viability assay kit
Letrozole and ruxolitinib demonstrate synergy in ovarian cancer cell lines. ERα-high ovarian cancer cell lines OVCAR3 and OVCAR8 were treated with a range of doses of ruxolitinib (Rux) and letrozole (Let) at ratio of 1:2 and <t>cell</t> <t>viability</t> quantified by <t>MTT</t> assay. The combination index (CI) was determined using Compusyn applying the Chou-Talalay method. ( A ) The CI relative to the fraction affected (Fa) is shown for OVCAR3 and OVCAR8. CI at 75% inhibition for each cell line is shown, with values < 1 indicating synergy. ( B ) Colony formation assay for OVCAR8 and graphical representation demonstrating synergy in the colony formation assay.
Cell Quanti Mtt Cell Viability Assay Kit, supplied by BioAssay Systems LLC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cell quanti-mtt cell viability assay kit/product/BioAssay Systems LLC
Average 90 stars, based on 1 article reviews
cell quanti-mtt cell viability assay kit - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
mtt assay  (Funakoshi ltd)
90
Funakoshi ltd mtt assay
Letrozole and ruxolitinib demonstrate synergy in ovarian cancer cell lines. ERα-high ovarian cancer cell lines OVCAR3 and OVCAR8 were treated with a range of doses of ruxolitinib (Rux) and letrozole (Let) at ratio of 1:2 and <t>cell</t> <t>viability</t> quantified by <t>MTT</t> assay. The combination index (CI) was determined using Compusyn applying the Chou-Talalay method. ( A ) The CI relative to the fraction affected (Fa) is shown for OVCAR3 and OVCAR8. CI at 75% inhibition for each cell line is shown, with values < 1 indicating synergy. ( B ) Colony formation assay for OVCAR8 and graphical representation demonstrating synergy in the colony formation assay.
Mtt Assay, supplied by Funakoshi ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mtt assay/product/Funakoshi ltd
Average 90 stars, based on 1 article reviews
mtt assay - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
mtt kits  (Beyotime)
90
Beyotime mtt kits
Letrozole and ruxolitinib demonstrate synergy in ovarian cancer cell lines. ERα-high ovarian cancer cell lines OVCAR3 and OVCAR8 were treated with a range of doses of ruxolitinib (Rux) and letrozole (Let) at ratio of 1:2 and <t>cell</t> <t>viability</t> quantified by <t>MTT</t> assay. The combination index (CI) was determined using Compusyn applying the Chou-Talalay method. ( A ) The CI relative to the fraction affected (Fa) is shown for OVCAR3 and OVCAR8. CI at 75% inhibition for each cell line is shown, with values < 1 indicating synergy. ( B ) Colony formation assay for OVCAR8 and graphical representation demonstrating synergy in the colony formation assay.
Mtt Kits, supplied by Beyotime, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mtt kits/product/Beyotime
Average 90 stars, based on 1 article reviews
mtt kits - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
ezcounttm mtt cell assay kit  (HiMedia Laboratories)
90
HiMedia Laboratories ezcounttm mtt cell assay kit
Letrozole and ruxolitinib demonstrate synergy in ovarian cancer cell lines. ERα-high ovarian cancer cell lines OVCAR3 and OVCAR8 were treated with a range of doses of ruxolitinib (Rux) and letrozole (Let) at ratio of 1:2 and <t>cell</t> <t>viability</t> quantified by <t>MTT</t> assay. The combination index (CI) was determined using Compusyn applying the Chou-Talalay method. ( A ) The CI relative to the fraction affected (Fa) is shown for OVCAR3 and OVCAR8. CI at 75% inhibition for each cell line is shown, with values < 1 indicating synergy. ( B ) Colony formation assay for OVCAR8 and graphical representation demonstrating synergy in the colony formation assay.
Ezcounttm Mtt Cell Assay Kit, supplied by HiMedia Laboratories, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ezcounttm mtt cell assay kit/product/HiMedia Laboratories
Average 90 stars, based on 1 article reviews
ezcounttm mtt cell assay kit - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
mtt kit  (Bimake Inc)
90
Bimake Inc mtt kit
Letrozole and ruxolitinib demonstrate synergy in ovarian cancer cell lines. ERα-high ovarian cancer cell lines OVCAR3 and OVCAR8 were treated with a range of doses of ruxolitinib (Rux) and letrozole (Let) at ratio of 1:2 and <t>cell</t> <t>viability</t> quantified by <t>MTT</t> assay. The combination index (CI) was determined using Compusyn applying the Chou-Talalay method. ( A ) The CI relative to the fraction affected (Fa) is shown for OVCAR3 and OVCAR8. CI at 75% inhibition for each cell line is shown, with values < 1 indicating synergy. ( B ) Colony formation assay for OVCAR8 and graphical representation demonstrating synergy in the colony formation assay.
Mtt Kit, supplied by Bimake Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mtt kit/product/Bimake Inc
Average 90 stars, based on 1 article reviews
mtt kit - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

Image Search Results


Letrozole and ruxolitinib demonstrate synergy in ovarian cancer cell lines. ERα-high ovarian cancer cell lines OVCAR3 and OVCAR8 were treated with a range of doses of ruxolitinib (Rux) and letrozole (Let) at ratio of 1:2 and cell viability quantified by MTT assay. The combination index (CI) was determined using Compusyn applying the Chou-Talalay method. ( A ) The CI relative to the fraction affected (Fa) is shown for OVCAR3 and OVCAR8. CI at 75% inhibition for each cell line is shown, with values < 1 indicating synergy. ( B ) Colony formation assay for OVCAR8 and graphical representation demonstrating synergy in the colony formation assay.

Journal: Cancers

Article Title: Inhibition of Tumor Microenvironment Cytokine Signaling Sensitizes Ovarian Cancer Cells to Antiestrogen Therapy

doi: 10.3390/cancers14194675

Figure Lengend Snippet: Letrozole and ruxolitinib demonstrate synergy in ovarian cancer cell lines. ERα-high ovarian cancer cell lines OVCAR3 and OVCAR8 were treated with a range of doses of ruxolitinib (Rux) and letrozole (Let) at ratio of 1:2 and cell viability quantified by MTT assay. The combination index (CI) was determined using Compusyn applying the Chou-Talalay method. ( A ) The CI relative to the fraction affected (Fa) is shown for OVCAR3 and OVCAR8. CI at 75% inhibition for each cell line is shown, with values < 1 indicating synergy. ( B ) Colony formation assay for OVCAR8 and graphical representation demonstrating synergy in the colony formation assay.

Article Snippet: Cell viability was determined with the MTT Cell Viability Assay Kit (Biotium, Fremont, CA, USA, Cat. No.30006).

Techniques: MTT Assay, Inhibition, Colony Assay